Scott I. Abrams

11.1k total citations · 1 hit paper
177 papers, 8.3k citations indexed

About

Scott I. Abrams is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Scott I. Abrams has authored 177 papers receiving a total of 8.3k indexed citations (citations by other indexed papers that have themselves been cited), including 139 papers in Immunology, 88 papers in Oncology and 51 papers in Molecular Biology. Recurrent topics in Scott I. Abrams's work include Immunotherapy and Immune Responses (71 papers), Immune cells in cancer (49 papers) and Immune Cell Function and Interaction (46 papers). Scott I. Abrams is often cited by papers focused on Immunotherapy and Immune Responses (71 papers), Immune cells in cancer (49 papers) and Immune Cell Function and Interaction (46 papers). Scott I. Abrams collaborates with scholars based in United States, Canada and Japan. Scott I. Abrams's co-authors include Jeffrey Schlom, Kebin Liu, James W. Hodge, Judy Kantor, Jeremy D. Waight, Mala Chakraborty, Kevin Camphausen, Elke S. Bergmann‐Leitner, Sheila A. Caldwell and Elizabeth A. Repasky and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Journal of Clinical Investigation.

In The Last Decade

Scott I. Abrams

169 papers receiving 8.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

A2A adenosine receptor protects tumors from antitumor T cells

2006 817 citations Akio Ohta, Elieser Gorelik et al. Proceedings of the National Academy of Sciences profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Scott I. Abrams United States	46	4.9k	3.7k	2.5k	710	652	177	8.3k
Kenneth I. Weinberg United States	51	4.1k 0.8×	2.2k 0.6×	3.9k 1.6×	438 0.6×	681 1.0×	180	10.8k
Masao Ono Japan	36	3.2k 0.7×	1.2k 0.3×	3.1k 1.3×	341 0.5×	451 0.7×	138	7.4k
Tsukasa Baba Japan	44	2.3k 0.5×	3.3k 0.9×	2.4k 1.0×	1.0k 1.5×	754 1.2×	184	7.5k
Ken Yamaguchi Japan	45	3.3k 0.7×	4.4k 1.2×	2.8k 1.1×	1.0k 1.4×	996 1.5×	312	9.5k
Emmanuelle Passegué United States	54	4.4k 0.9×	3.0k 0.8×	7.8k 3.1×	2.1k 2.9×	843 1.3×	98	15.3k
Douglas C. Palmer United States	43	8.2k 1.7×	7.4k 2.0×	3.1k 1.2×	769 1.1×	262 0.4×	88	12.1k
Alison H. Banham United Kingdom	48	5.1k 1.0×	3.1k 0.8×	3.5k 1.4×	2.1k 3.0×	580 0.9×	147	10.5k
Howard C. Crawford United States	56	1.8k 0.4×	5.0k 1.3×	5.4k 2.1×	2.8k 3.9×	695 1.1×	139	11.0k
Yutaka Kawakami Japan	62	9.0k 1.8×	5.5k 1.5×	6.0k 2.4×	876 1.2×	786 1.2×	263	15.1k
Joanne E. Murphy-Ullrich United States	56	2.2k 0.4×	1.4k 0.4×	5.8k 2.3×	1.8k 2.5×	1.3k 2.0×	111	11.3k

Countries citing papers authored by Scott I. Abrams

Since Specialization

Citations

This map shows the geographic impact of Scott I. Abrams's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Scott I. Abrams with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Scott I. Abrams more than expected).

Fields of papers citing papers by Scott I. Abrams

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Scott I. Abrams. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Scott I. Abrams. The network helps show where Scott I. Abrams may publish in the future.

Co-authorship network of co-authors of Scott I. Abrams

This figure shows the co-authorship network connecting the top 25 collaborators of Scott I. Abrams. A scholar is included among the top collaborators of Scott I. Abrams based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Scott I. Abrams. Scott I. Abrams is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Hutson, Alan D., et al.. (2024). Differences in Immune Cell Populations between Individuals with or without MGUS. Blood. 144(Supplement 1). 4678–4678.

Song, Yiting, et al.. (2024). Identification of Enhanced Vaccine Mimotopes for the p15E Murine Cancer Antigen. Cancer Research Communications. 4(4). 958–969. 2 indexed citations

Zhang, Lixia, Kyu Hwan Kwack, Ramkumar Thiyagarajan, et al.. (2023). Tristetraprolin regulates the skeletal phenotype and osteoclastogenic potential through monocytic myeloid‐derived suppressor cells. The FASEB Journal. 38(1). e23338–e23338. 4 indexed citations

Amitrano, Andrea M., Jennifer Peresie, Brian Morreale, et al.. (2022). Inhibiting the biogenesis of myeloid-derived suppressor cells enhances immunotherapy efficacy against mammary tumor progression. Journal of Clinical Investigation. 132(23). 32 indexed citations

Dai, Tao, Spencer R. Rosario, Eriko Katsuta, et al.. (2022). Hypoxic activation of PFKFB4 in breast tumor microenvironment shapes metabolic and cellular plasticity to accentuate metastatic competence. Cell Reports. 41(10). 111756–111756. 14 indexed citations

He, Xuedan, Wei‐Chiao Huang, Dushyant Jahagirdar, et al.. (2021). Position‐Scanning Peptide Libraries as Particle Immunogens for Improving CD8⁺ T‐Cell Responses. Advanced Science. 8(24). e2103023–e2103023. 7 indexed citations

Patel, Ankit, et al.. (2021). Multimodal Intralesional Therapy for Reshaping the Myeloid Compartment of Tumors Resistant to Anti–PD-L1 Therapy via IRF8 Expression. The Journal of Immunology. 207(5). 1298–1309. 10 indexed citations

He, Xuedan, Melissa Dolan, Yuhao Shi, et al.. (2021). Immunization with short peptide particles reveals a functional CD8⁺ T-cell neoepitope in a murine renal carcinoma model. Journal for ImmunoTherapy of Cancer. 9(12). e003101–e003101. 20 indexed citations

Khan, A. Nazmul H., Tiffany R. Emmons, Jerry Wong, et al.. (2020). Quantification of Early-Stage Myeloid-Derived Suppressor Cells in Cancer Requires Excluding Basophils. Cancer Immunology Research. 8(6). 819–828. 33 indexed citations

10.

Knudsen, Erik S., Vishnu Kumarasamy, Sejin Chung, et al.. (2020). Targeting dual signalling pathways in concert with immune checkpoints for the treatment of pancreatic cancer. Gut. 70(1). 127–138. 59 indexed citations

11.

Yao, Song, Ting‐Yuan David Cheng, Ahmed Elkhanany, et al.. (2020). Breast Tumor Microenvironment in Black Women: A Distinct Signature of CD8+ T-Cell Exhaustion. JNCI Journal of the National Cancer Institute. 113(8). 1036–1043. 59 indexed citations

12.

Orillion, Ashley, Nur P. Damayanti, Li Shen, et al.. (2018). Dietary Protein Restriction Reprograms Tumor-Associated Macrophages and Enhances Immunotherapy. Clinical Cancer Research. 24(24). 6383–6395. 85 indexed citations

13.

Hashimoto, Ayumi, Chan Gao, Jérôme Mastio, et al.. (2018). Inhibition of Casein Kinase 2 Disrupts Differentiation of Myeloid Cells in Cancer and Enhances the Efficacy of Immunotherapy in Mice. Cancer Research. 78(19). 5644–5655. 43 indexed citations

14.

Hong, Chi‐Chen, Lara E. Sucheston‐Campbell, Song Liu, et al.. (2018). Genetic Variants in Immune-Related Pathways and Breast Cancer Risk in African American Women in the AMBER Consortium. Cancer Epidemiology Biomarkers & Prevention. 27(3). 321–330. 16 indexed citations

15.

He, Xuedan, Scott I. Abrams, & Jonathan F. Lovell. (2018). Peptide Delivery Systems for Cancer Vaccines. Advanced Therapeutics. 1(5). 34 indexed citations

16.

Bucsek, Mark J., Guanxi Qiao, Cameron R. MacDonald, et al.. (2017). β-Adrenergic Signaling in Mice Housed at Standard Temperatures Suppresses an Effector Phenotype in CD8+ T Cells and Undermines Checkpoint Inhibitor Therapy. Cancer Research. 77(20). 5639–5651. 206 indexed citations

17.

Singh, Anurag K., Mohammad Habiby Kermany, Austin Miller, et al.. (2017). A Pilot Study of Stereotactic Body Radiation Therapy Combined with Cytoreductive Nephrectomy for Metastatic Renal Cell Carcinoma. Clinical Cancer Research. 23(17). 5055–5065. 65 indexed citations

18.

Shen, Li, Anette Sundstedt, Michael J. Ciesielski, et al.. (2014). Tasquinimod Modulates Suppressive Myeloid Cells and Enhances Cancer Immunotherapies in Murine Models. Cancer Immunology Research. 3(2). 136–148. 74 indexed citations

19.

Kokolus, Kathleen M., Maegan L. Capitano, Chen-Ting Lee, et al.. (2013). Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature. Proceedings of the National Academy of Sciences. 110(50). 20176–20181. 251 indexed citations

20.

Ohta, Akio, Elieser Gorelik, Simon J. Prasad, et al.. (2006). A2A adenosine receptor protects tumors from antitumor T cells. Proceedings of the National Academy of Sciences. 103(35). 13132–13137. 817 indexed citations breakdown →

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact